15th Jan 2007 16:39
ReGen Therapeutics PLC15 January 2007 SUBSTANTIAL SHAREHOLDING London, UK - 15 January, 2007: ReGen Therapeutics Plc (the "Company") announcesthat it has today received notification from Mr Tigran Kalaydjian that he hasacquired 1,000,000 ordinary shares of the Company at 1.05p per share. MrKalaydjian now holds and is beneficially interested in 22,000,000 ordinaryshares representing 3.17% of the current issued share capital of the Company. For further information, please contact: Andrew MarshallTel. 020 7960 6007Greycoat Communications This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.L